CEA, found on the surface of malignant tumor cells, is recognized as a broad-spectrum tumor marker, used in treatment monitoring and prognosis assessment, and is characteristic for colorectal cancer while having a low specificity in other cancers [7,24]. This evidence concerns the gene CEACAM5 and cancer.